References
[1] T. Bieber, “Atopic dermatitis,” N. Engl. J. Med., vol. 358, no. 14, pp. 1483–1494, Apr. 2008, doi: 10.1056/NEJMra074081.
[2] B. Kamer, R. Pasowska, E. Dółka, A. Blomberg, and H. Rotsztejn, “Prevalence of atopic dermatitis in infants during the first six months of life: authors’ observations,” Postepy Dermatol Alergol, vol. 30, no. 5, pp. 277–281, Oct. 2013, doi: 10.5114/pdia.2013.38355.
[3] Hill, D. A. & Spergel, J. M. The Atopic March: Critical Evidence and Clinical Relevance. Ann Allergy Asthma Immunol 120, 131–137 (2018).
[4] C. M. Olesen et al., “Altered Maturation of the Skin Microbiome in Infants with Atopic Dermatitis,” Acta Derm. Venereol., vol. 102, p. adv00817, Nov. 2022, doi: 10.2340/actadv.v102.2275.
[5] I. R. Serghiou, M. A. Webber, and L. J. Hall, “An update on the current understanding of the infant skin microbiome and research challenges,” Curr. Opin. Microbiol., vol. 75, p. 102364, Oct. 2023, doi: 10.1016/j.mib.2023.102364.
[6] Z. Aversa et al., “Association of Infant Antibiotic Exposure With Childhood Health Outcomes,” Mayo Clin. Proc., vol. 96, no. 1, Art. no. 1, Jan. 2021, doi: 10.1016/j.mayocp.2020.07.019.
[7] S. E. Zven, A. Susi, E. Mitre, and C. M. Nylund, “Association Between Use of Multiple Classes of Antibiotic in Infancy and Allergic Disease in Childhood,” JAMA Pediatr., vol. 174, no. 2, Art. no. 2, Feb. 2020, doi: 10.1001/jamapediatrics.2019.4794.
[8] P. A. Nieto et al., "Improving immune-related health outcomes post-cesarean birth with a gut microbiome-based program: A randomized controlled trial," Pediatric Allergy and Immunology, vol. 36, no. 9, p. e70182, 2025, doi: 10.1111/pai.70182.
[9] B. De Pessemier, L. Grine, M. Debaere, A. Maes, B. Paetzold, and C. Callewaert, “Gut-Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions,” Microorganisms, vol. 9, no. 2, p. 353, Feb. 2021, doi: 10.3390/microorganisms9020353.
[10] I. Salem, A. Ramser, N. Isham, and M. A. Ghannoum, “The Gut Microbiome as a Major Regulator of the Gut-Skin Axis,” Front. Microbiol., vol. 9, p. 1459, 2018, doi: 10.3389/fmicb.2018.01459.
[11] S. P. Wiertsema et al., “The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies,” Nutrients, vol. 13, no. 3, p. 886, Mar. 2021, doi: 10.3390/nu13030886.
[12] T. Gensollen, S. S. Iyer, D. L. Kasper, and R. S. Blumberg, “How colonization by microbiota in early life shapes the immune system,” Science, vol. 352, no. 6285, pp. 539–544, 2016, doi: 10.1126/science.aad9378.
[13] H. Renz, P. G. Holt, M. Inouye, A. C. Logan, S. L. Prescott, and P. D. Sly, “An exposome perspective: Early-life events and immune development in a changing world,” J Allergy Clin Immun, vol. 140, no. 1, pp. 24–40, 2017, doi: 10.1016/j.jaci.2017.05.015.
[14] E. Lee et al., “Prenatal mold exposure is associated with development of atopic dermatitis in infants through allergic inflammation,” J. Pediatr. (Rio J.), vol. 96, no. 1, pp. 125–131, 2020, doi: 10.1016/j.jped.2018.07.012.
[15] S. Kraft, L. Buchenauer, and T. Polte, “Mold, Mycotoxins and a Dysregulated Immune System: A Combination of Concern?,” Int. J. Mol. Sci., vol. 22, no. 22, p. 12269, Nov. 2021, doi: 10.3390/ijms222212269.
[16] T. Nobles, S. Harberger, and K. Krishnamurthy, “Cradle Cap,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2025. Accessed: Nov. 03, 2025. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK531463/
[17] “Seborrheic dermatitis: Learn More – Seborrheic dermatitis in babies (cradle cap),” in InformedHealth.org, Institute for Quality and Efficiency in Health Care (IQWiG), 2024. Accessed: Nov. 03, 2025. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK559360/